We are live on ! Find out more
KURA icon

Kura Oncology
KURA

127 hedge funds and large institutions have $537M invested in Kura Oncology in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

53% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 32

49% more call options, than puts

Call options by funds: $233K | Put options by funds: $156K

9% more funds holding

Funds holding: 116 → 127 (+11)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2.83% less ownership

Funds ownership: 88.99% → 86.16% (-2.8%)

12% less capital invested

Capital invested by funds: $610M → $537M (-$73.4M)

Holders
127
Holders Change
+11
Holders Change %
+9.48%
% of All Funds
2.5%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
24
Increased
49
Reduced
32
Closed
7
Calls
$233K
Puts
$156K
Net Calls
+$77K
Net Calls Change
+$55K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.33M
2
Goldman Sachs
Goldman Sachs
New York
+$6.48M
3
EC
EcoR1 Capital
California
+$2.96M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.37M
5
AG
Artal Group
Luxembourg
+$2.22M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$33.1M
2
AVM
Arch Venture Management
Illinois
-$7.41M
3
DCM
Driehaus Capital Management
Illinois
-$6.31M
4
CAM
Cormorant Asset Management
Massachusetts
-$3.43M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$2.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Acuta Capital Partners
California
$3.3M +$2.15M +145,000 +153%
ORI
27
Oak Ridge Investments
Illinois
$2.88M -$734K -49,542 -19%
Two Sigma Investments
28
Two Sigma Investments
New York
$2.48M +$1.73M +116,777 +183%
EAM
29
Erste Asset Management
Austria
$2.45M +$1.94M +131,000 +320%
DCM
30
DAFNA Capital Management
California
$2.38M +$1.03M +69,817 +67%
WCM Investment Management
31
WCM Investment Management
California
$2.29M +$2.19M +147,780 +778%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$2.19M +$2.37M +159,612 New
BG
33
Bellevue Group
Switzerland
$2.17M -$126K -8,500 -5%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.99M +$56.6K +3,821 +3%
OAM
35
Oxford Asset Management
United Kingdom
$1.85M +$228K +15,367 +13%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$1.85M +$1.25M +84,100 +167%
CIA
37
Capital Impact Advisors
Massachusetts
$1.82M +$149K +10,071 +8%
Squarepoint
38
Squarepoint
New York
$1.78M +$695K +46,878 +57%
KCM
39
Kennedy Capital Management
Missouri
$1.5M -$72.3K -4,879 -4%
Man Group
40
Man Group
United Kingdom
$1.46M -$2.18M -147,446 -58%
CAM
41
ClariVest Asset Management
California
$1.34M -$672K -45,342 -32%
AA
42
ALPS Advisors
Colorado
$1.26M +$27.8K +1,879 +2%
AGA
43
Altrinsic Global Advisors
Connecticut
$1.24M – – –
Bank of America
44
Bank of America
North Carolina
$1.15M -$226K -15,275 -15%
MA
45
Minerva Advisors
Pennsylvania
$1.06M -$128K -8,665 -10%
Deutsche Bank
46
Deutsche Bank
Germany
$1.03M +$46.7K +3,154 +4%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.01M +$403K +27,200 +59%
CCP
48
Clough Capital Partners
Massachusetts
$972K -$29.6K -2,000 -3%
Morgan Stanley
49
Morgan Stanley
New York
$949K +$611K +41,261 +148%
FCMI
50
Foresite Capital Management IV
California
$935K +$1.01M +68,000 New
1
2
3 4 5

KURA Hedge Fund Activity: Q4 2019 in Review

127 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2019, worth a combined $537M — down 12% from $610M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KURA positions and 7 closed out — a net gain of 17 holders — while 49 added to existing stakes and 32 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $9.33M. The largest seller was Great Point Partners, cutting an estimated $33.1M.

  • 127 institutional investors held Kura Oncology (KURA) as of Q4 2019, up from 116 in Q3 2019.
  • Funds reported $537M of Kura Oncology stock for Q4 2019, down 12% quarter-over-quarter.
  • 24 funds opened new Kura Oncology positions in Q4 2019 and 7 closed out, a net change of +17 holders.
  • The largest Kura Oncology buyer in Q4 2019 was Millennium Management, an estimated $9.33M added.
  • The largest Kura Oncology seller in Q4 2019 was Great Point Partners, an estimated $33.1M sold.

Based on aggregated 13F filings for Q4 2019.